Table 3.

Multivariable GLM results for total annual healthcare expenditure in patients with RA.

Mean Ratio, (95% CI)aMean Difference, 2015 US$ (95% CI)b
Hypertension1.23 (1.06–1.43)*2343 (605–4079)*
Lipid metabolism disorders0.95 (0.83–1.09)535 (−1993 to 923)
Diabetes1.24 (1.08–1.43)*2603 (813–4393)*
Depression1.40 (1.21–1.61)**4235 (2167–6301)**
Eye and adnexa disorders1.22 (1.05–1.42)*2407 (440–4373)*
Asthma1.09 (0.92–1.28)968 (−961 to 2896)
COPD1.46 (1.26–1.69)**4972 (2633–7311)**
Cancer1.32 (1.13–1.53)**3372 (1322–5423)*
Myocardial infarction1.60 (1.27–2.01)**6511 (2699–10,323)*
Osteoporosis1.27 (1.05–1.53)*2925 (318–5531)*
Stroke1.47 (1.19–1.82)**5150 (1764–8536)*
Heart failure1.75 (1.38–2.22)**8205 (3683–12,726)**
Sex (ref: male)
      Female1.13 (0.99–1.30)
Age1.00 (0.99–1.01)
Region (ref: West)
      Northeast1.19 (0.97–1.46)
      Midwest1.26 (1.03–1.55)*
      South1.06 (0.90–1.25)
Insurance coverage (ref: public only)
      Any private0.97 (0.84–1.13)
      No insurance0.52 (0.43–0.62)**
Education (ref: high school not completed)
      High school completed1.07 (0.93–1.24)
      Bachelor degree1.56 (1.21–2.01)*
      Postgraduate degree1.36 (0.98–1.89)
      Other degree1.33 (1.12–1.59)*
Smoking status (ref: nonsmoker)
      Smoker0.80 (0.67–0.95)*
  • a Values are the exponential form of the β coefficients for a covariate, which represents the multiplier factor for the outcome when the covariate increases by 1; the reference for each comorbidity is absence of the condition.

  • b Values are the average marginal effect for a comorbidity compared to absence of the condition, holding all other covariates at the average values.

  • * P < 0.05.

  • ** P < 0.001.

  • COPD: chronic obstructive pulmonary disease; GLM: generalized linear model; RA: rheumatoid arthritis.